Article | Page(s) | View |
---|
BOARDS OF APPEAL |
Decisions of the Technical Boards of Appeal |
Decision of Technical Board of Appeal 3.2.1 dated 4 April 1991 – T 328/87 | 701-709 | PDF | HTML |
Decision of Technical Board of Appeal 3.3.3 dated 25 April 1991 – T 238/88 | 709-717 | PDF | HTML |
Decision of Technical Board of Appeal 3.3.3 dated 15 November 1990 – T 93/89 | 718-724 | PDF | HTML |
Decision of Technical Board of Appeal 3.3.2 dated 24 April 1991 – T 560/89 | 725-736 | PDF | HTML |
Decision of Technical Board of Appeal 3.4.1 dated 24 April 1991 – T 3/90 | 737-738 | PDF | HTML |
Decision of Technical Board of Appeal 3.4.1 dated 14 August 1991 – T 669/90 | 739-746 | PDF | HTML |
DECISIONS OF THE EXAMINING AND OPPOSITION DIVISIONS |
Decision of the Opposition Division dated 13 May 1992 | 747-752 | PDF | HTML |
INFORMATION FROM THE EPO |
Official Journal Index, Year 15/1992 | Insert | PDF | |
Notices of the President of the EPO |
Notice of the President of the European Patent Office dated 1 December 1992 concerning accelerated prosecution of European patent applications ["Seven Measures"] | 753-755 | PDF | HTML |
Notice of the President of the European Patent Office dated 9 October 1992 concerning the days on which EPO filing offices are closed in 1993 | 756 | PDF | HTML |
Information from the EPO |
Representation of nucleotide and amino acid sequences in patent applications and filing of sequence listings | 757 | PDF | HTML |
Notice from the European Patent Office dated 16 October 1992 concerning the revised Request for Grant form | 757-774 | PDF | HTML |
Notice dated 16 October 1992 concerning revised Form 1200 | 775-790 | PDF | HTML |
Trilateral Statistical Report for 1991 | 791 | PDF | HTML |
REPRESENTATION |
List of professional representatives before the EPO |
List of professional representatives before the EPO | 792-797 | PDF | |
INFORMATION FROM THE CONTRACTING / EXTENSION STATES |
DE Germany |
Decision of the Bundesgerichtshof (Federal Court of Justice), Xth Civil Senate, of 11 June 1991 (X ZB 24/89) | 798-806 | PDF | HTML |
ES Spain |
Change of name of the Spanish Patent Office | 806 | PDF | HTML |
PT Portugal |
Impact of the European Patent Convention on national law | 806-811 | PDF | HTML |
INTERNATIONAL TREATIES |
General |
EEC Treaty Supplementary Protection Certificate for Medicinal Products | 812-821 | PDF | HTML |
PCT |
Agreement between the EPO and WIPO under the PCT Corrigendum | 821 | PDF | HTML |
Information for PCT applicants | 821 | PDF | HTML |
FEES |
Important Notice |
Important notice | 822 | PDF | |
Supplements
Supplement No. 1 to OJ 12/1992
Information for PCT applicants (as at 1 January 1993): concerning time limits and procedural steps before the EPO as a designated Office under the PCT (Arts. 150, 153, Rule 104b EPC)
This supplement does not contain separate articles. | PDF | |
Supplement No. 2 to OJ 12/1992
Decision of the President of the European Patent Office dated 11 December 1992 concerning the representation of nucleotide and amino acid sequences in patent applications and the filing of sequence listings
This supplement does not contain separate articles. | PDF | |
Supplement No. 3 to OJ 12/1992
Decision of the President of the European Patent Office dated 26 November 1992 concerning the revision of equivalents and prices of the EPO
This supplement does not contain separate articles. | PDF | |